These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND KMT2C, ENSG00000055609, MLL3, 58508
33 results:

  • 1. Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer.
    Chen SH; Tse KP; Lu YJ; Chen SJ; Tian YF; Tan KT; Li CF
    Cancer Med; 2024 Jun; 13(12):e7384. PubMed ID: 38895905
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. kmt2c mutation as a predictor of immunotherapeutic efficacy in colorectal cancer.
    Ni C; Wang X; Liu S; Zhang J; Luo Z; Xu B
    Sci Rep; 2024 Apr; 14(1):8284. PubMed ID: 38594266
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mutational profile evaluates metastatic capacity of Chinese colorectal cancer patients, revealed by whole-exome sequencing.
    Yang Y; Chen J; Peng H; Xiao Z; Xu W; Zheng M; Li Z; Cao P
    Genomics; 2024 May; 116(3):110809. PubMed ID: 38492821
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines.
    Cheng F; Li P; Xu S; Zhang C; Liang H; Ding Z
    Aging (Albany NY); 2024 Feb; 16(5):4396-4422. PubMed ID: 38407980
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study.
    Ma YT; Hua F; Zhong XM; Xue YJ; Li J; Nie YC; Zhang XD; Ma JW; Lin CH; Zhang HZ; He W; Sha D; Zhao MQ; Yao ZG
    Front Immunol; 2023; 14():1269097. PubMed ID: 38022513
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer.
    Gimeno-Valiente F; Martín-Arana J; Tébar-Martínez R; Gambardella V; Martínez-Ciarpaglini C; García-Micó B; Martínez-Castedo B; Palomar B; García-Bartolomé M; Seguí V; Huerta M; Moro-Valdezate D; Pla-Martí V; Pérez-Santiago L; Roselló S; Roda D; Cervantes A; Tarazona N
    ESMO Open; 2023 Dec; 8(6):102051. PubMed ID: 37951129
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pathogenic alterations in PIK3CA and kmt2c are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
    Hamza A; Masliah-Planchon J; Neuzillet C; Lefèvre JH; Svrcek M; Vacher S; Bourneix C; Delaye M; Goéré D; Dartigues P; Samalin E; Hilmi M; Lazartigues J; Girard E; Emile JF; Rigault E; Dangles-Marie V; Rioux-Leclercq N; de la Fouchardière C; Tougeron D; Casadei-Gardini A; Mariani P; Peschaud F; Cacheux W; Lièvre A; Bièche I
    Int J Cancer; 2024 Feb; 154(3):504-515. PubMed ID: 37908048
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Deciphering Brain Metastasis Stem Cell Properties From colorectal cancer Highlights Specific Stemness Signature and Shared Molecular Features.
    Desette A; Guichet PO; Emambux S; Masliantsev K; Cortes U; Ndiaye B; Milin S; George S; Faigner M; Tisserand J; Gaillard A; Brot S; Wager M; Tougeron D; Karayan-Tapon L
    Cell Mol Gastroenterol Hepatol; 2023; 16(5):757-782. PubMed ID: 37482243
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular typing and mutational characterization of rectal neuroendocrine neoplasms.
    Duan X; Zhao M; Yin X; Mi L; Shi J; Li N; Han X; Han G; Wang J; Hou J; Yin F
    Cancer Med; 2023 Aug; 12(15):16207-16220. PubMed ID: 37387515
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comparison of genetic variation between primary colorectal cancer and metastatic peritoneal cancer.
    Shin W; Yun J; Han K; Park DG
    Genes Genomics; 2023 Aug; 45(8):989-1001. PubMed ID: 37277571
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Therapeutic targeting of metabolic vulnerabilities in cancers with mll3/4-COMPASS epigenetic regulator mutations.
    Zhao Z; Cao K; Watanabe J; Philips CN; Zeidner JM; Ishi Y; Wang Q; Gold SR; Junkins K; Bartom ET; Yue F; Chandel NS; Hashizume R; Ben-Sahra I; Shilatifard A
    J Clin Invest; 2023 Jul; 133(13):. PubMed ID: 37252797
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genomic characteristics and prognosis of lung cancer patients with MSI-H: A cohort study.
    Tian J; Wang H; Lu C; Liu L; Zhang X; Xie Y; Li R; Lv X; Fu D; Zhang L; Fang X; Wang X; Hu J; Liu X; Huang X; Zhao Q; Luo N; Tang H; Zhong Z; He Y; Li L
    Lung Cancer; 2023 Jul; 181():107255. PubMed ID: 37244039
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions.
    Tan X; Xu L; Jian X; Ouyang J; Hu B; Yang X; Wang T; Xie L
    Cells; 2023 Mar; 12(5):. PubMed ID: 36899918
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Association of kmt2c/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.
    Liu R; Niu Y; Liu C; Zhang X; Zhang J; Shi M; Zou W; Gu B; Zhu H; Wang D; Yuan H; Li W; Zhao D; Zheng Q; Liu R; Chen W; Ma T; Zhang Y
    Cancer Sci; 2023 Apr; 114(4):1229-1239. PubMed ID: 36601880
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Restoration of kmt2c/mll3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression.
    Larsson C; Cordeddu L; Siggens L; Pandzic T; Kundu S; He L; Ali MA; Pristovšek N; Hartman K; Ekwall K; Sjöblom T
    Clin Epigenetics; 2020 May; 12(1):74. PubMed ID: 32471474
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. cancer-derived UTX TPR mutations G137V and D336G impair interaction with mll3/4 complexes and affect UTX subcellular localization.
    Kato H; Asamitsu K; Sun W; Kitajima S; Yoshizawa-Sugata N; Okamoto T; Masai H; Poellinger L
    Oncogene; 2020 Apr; 39(16):3322-3335. PubMed ID: 32071397
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Impact of Patient Age on Molecular Alterations of Left-Sided colorectal Tumors.
    Puccini A; Lenz HJ; Marshall JL; Arguello D; Raghavan D; Korn WM; Weinberg BA; Poorman K; Heeke AL; Philip PA; Shields AF; Goldberg RM; Salem ME
    Oncologist; 2019 Mar; 24(3):319-326. PubMed ID: 30018131
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mutant p53 regulates enhancer-associated H3K4 monomethylation through interactions with the methyltransferase MLL4.
    Rahnamoun H; Hong J; Sun Z; Lee J; Lu H; Lauberth SM
    J Biol Chem; 2018 Aug; 293(34):13234-13246. PubMed ID: 29954944
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Uncommon somatic mutations in metastatic NUT midline carcinoma.
    Cavalieri S; Stathis A; Fabbri A; Sonzogni A; Perrone F; Tamborini E; Pelosi G; de Braud F; Platania M
    Tumori; 2017 Nov; 103(Suppl. 1):e5-e8. PubMed ID: 28967088
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mutational Landscapes of Smoking-Related cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive cancer Center.
    Kytola V; Topaloglu U; Miller LD; Bitting RL; Goodman MM; D Agostino RB; Desnoyers RJ; Albright C; Yacoub G; Qasem SA; DeYoung B; Thorsson V; Shmulevich I; Yang M; Shcherban A; Pagni M; Liu L; Nykter M; Chen K; Hawkins GA; Grant SC; Petty WJ; Alistar AT; Levine EA; Staren ED; Langefeld CD; Miller V; Singal G; Petro RM; Robinson M; Blackstock W; Powell BL; Wagner LI; Foley KL; Abraham E; Pasche B; Zhang W
    Theranostics; 2017; 7(11):2914-2923. PubMed ID: 28824725
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 2.